Second-Line Modified FOLFOX6 Regimen in The Patients with Metastatic Esophagus Cancer.
Dogan KocaOguzhan OzdemirDavut DemirHuseyin AkdenizMehmet KurtPublished in: Hepato-gastroenterology (2016)
mFOLFOX6 regimen as a second line treatment can be applied to the mEC patients with progressive disease following CF chemotherapy.